The Combination of Inflammatory Biomarkers as Prognostic Indicator in Salivary Gland Malignancy

SIMPLE SUMMARY: Clinical management of Malignant Salivary Gland Tumors is still a challenge for clinicians. Direct and indirect costs for the diagnosis and treatment of these tumors are significant. For this reason, the need to develop a fast and low-cost prognostic system to stratify patients at hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbate, Vincenzo, Barone, Simona, Troise, Stefania, Laface, Claudia, Bonavolontà, Paola, Pacella, Daniela, Salzano, Giovanni, Iaconetta, Giorgio, Califano, Luigi, Dell’Aversana Orabona, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740974/
https://www.ncbi.nlm.nih.gov/pubmed/36497416
http://dx.doi.org/10.3390/cancers14235934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740974/
https://www.ncbi.nlm.nih.gov/pubmed/36497416
http://dx.doi.org/10.3390/cancers14235934

Ejemplares similares